naltrexone has been researched along with Diffuse Myofascial Pain Syndrome in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 9 (42.86) | 24.3611 |
| 2020's | 11 (52.38) | 2.80 |
| Authors | Studies |
|---|---|
| Amris, K; Blichfeldt-Eckhardt, MR; Bruun, KD; Christensen, R; Holsgaard-Larsen, A; Toft, P; Vaegter, HB | 1 |
| Borràs, X; Colomer-Carbonell, A; D'Amico, F; Feliu-Soler, A; García-Palacios, A; Hernández-Negrín, H; Luciano, JV; Maes, M; Muchart, J; Munuera, J; Rozadilla-Sacanell, A; Sanabria-Mazo, JP; Suso-Ribera, C; Younger, JW | 1 |
| Miller, CS; Sangalli, L | 1 |
| Aitcheson, N; Lin, Z; Tynan, K | 1 |
| DeSanto, K; Huang, H; Lyon, C; Radi, R; Rivera, J | 1 |
| Amris, K; Blichfeldt-Eckhardt, MR; Bruun-Plesner, K; Lauridsen, JT; Toft, P; Vaegter, HB | 1 |
| Rothschild, B | 1 |
| Fishman, MA; Kim, PS | 1 |
| Gillman, MA | 1 |
| Ashman, L; Hatfield, E; Phillips, K; Swidan, S | 1 |
| Akbik, H; Atluri, S; Buenaventura, R; Dann, T; Ferguson, K; Italiano, J; Sachdeva, H; Soin, A; Soin, Y; Sudarshan, G | 1 |
| Arkfeld, DG; Chen, CL; Metyas, S; Solyman, J; Yeter, K | 1 |
| Berlau, DJ; Patten, DK; Schultz, BG | 1 |
| Faraone, S; Johnson, B; Middleton, B; Oaks, Z; Stage, A | 1 |
| Baumrucker, SJ; Trofimovitch, D | 1 |
| McLain, D; Parkitny, L; Younger, J | 1 |
| Handberg, G; Plesner, KB; Vægter, HB | 1 |
| Johnson, J; Sheth, S | 1 |
| Cummins, ET; Younger, JW; Zautra, AJ | 1 |
| Guymer, EK; Littlejohn, GO; Ngian, GS | 1 |
| Mackey, S; McCue, R; Noor, N; Younger, J | 1 |
9 review(s) available for naltrexone and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
Low-dose naltrexone in the treatment of fibromyalgia: A systematic review and narrative synthesis.
Topics: Chronic Pain; Fibromyalgia; Humans; Naltrexone; Prospective Studies | 2023 |
Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review.
Topics: Chronic Pain; Fibromyalgia; Humans; Multiple Sclerosis; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders | 2020 |
Use of low-dose naltrexone in the management of chronic pain conditions: A systematic review.
Topics: Chronic Pain; Fibromyalgia; Humans; Naltrexone; Pain Management; Quality of Life | 2020 |
Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome: A Systematic Literature Review.
Topics: Animals; Chronic Pain; Fibromyalgia; Humans; Naltrexone; Prospective Studies; Retrospective Studies; United States | 2021 |
The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders.
Topics: Animals; Anti-Inflammatory Agents; Chronic Pain; Crohn Disease; Dose-Response Relationship, Drug; Fibromyalgia; Humans; Inflammation; Multiple Sclerosis; Naltrexone; Narcotic Antagonists; Quality of Life | 2018 |
Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes.
Topics: Analgesics, Non-Narcotic; Cancer Pain; Chronic Pain; Complex Regional Pain Syndromes; Diabetic Neuropathies; Dose-Response Relationship, Drug; Fibromyalgia; Humans; Naltrexone; Pain Management; Palliative Care; Quality of Life | 2019 |
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain.
Topics: Anti-Inflammatory Agents; Chronic Pain; Fibromyalgia; Humans; Naltrexone; Neuroglia | 2014 |
[Low dose naltrexone for treatment of pain].
Topics: Analgesics, Opioid; Crohn Disease; Fibromyalgia; Humans; Multiple Sclerosis; Naltrexone; Narcotic Antagonists; Pain | 2015 |
The use of opioids in fibromyalgia.
Topics: Analgesics, Opioid; Evidence-Based Medicine; Fibromyalgia; Humans; Naltrexone; Pain; Practice Guidelines as Topic; Tramadol; Treatment Failure | 2011 |
7 trial(s) available for naltrexone and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial.
Topics: Double-Blind Method; Female; Fibromyalgia; Humans; Naltrexone; Pain; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost-utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study).
Topics: Adult; Clinical Trials, Phase III as Topic; Double-Blind Method; Fibromyalgia; Humans; Naltrexone; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic | 2022 |
Is low-dose naltrexone effective in chronic pain management?
Topics: Amitriptyline; Fibromyalgia; Humans; Naltrexone; Pain; Pain Management | 2023 |
Low-Dose Naltrexone for the Treatment of Fibromyalgia: Investigation of Dose-Response Relationships.
Topics: Adolescent; Adult; Female; Fibromyalgia; Humans; Middle Aged; Naltrexone; Outcome Assessment, Health Care; Pain Clinics; Single-Blind Method; Treatment Outcome; Young Adult | 2020 |
Low Dose Naltrexone in the Treatment of Fibromyalgia.
Topics: Adult; Aged; Female; Fibromyalgia; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Treatment Outcome | 2018 |
Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology.
Topics: Double-Blind Method; Female; Fibromyalgia; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pain Measurement; Pain Threshold; Placebos; Substance Withdrawal Syndrome; Treatment Outcome | 2009 |
Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
Topics: Adult; Aged; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fibromyalgia; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Pain; Pain Measurement; Placebos; Self Report; Treatment Outcome | 2013 |
5 other study(ies) available for naltrexone and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
Low-dose naltrexone for treatment of burning mouth syndrome.
Topics: Burning Mouth Syndrome; Clonazepam; Female; Fibromyalgia; Headache; Humans; Middle Aged; Naltrexone; Pain | 2023 |
Role of Opioids in Fibromyalgia and Its Resistance to Therapy.
Topics: Analgesics, Opioid; Fibromyalgia; Humans; Naltrexone; Role | 2020 |
Dual Opioid Systems: A Simpler Explanation for Naltrexone Efficacy in Fibromyalgia.
Topics: Analgesics, Opioid; Fibromyalgia; Humans; Naltrexone; Narcotic Antagonists | 2021 |
Clinical utility of the cold pressor test: evaluation of pain patients, treatment of opioid-induced hyperalgesia and fibromyalgia with low dose naltrexone.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Dose-Response Relationship, Drug; Female; Fibromyalgia; Humans; Hyperalgesia; Male; Middle Aged; Naltrexone; Opioid-Related Disorders; Pain Management; Pain Measurement; Pain Threshold; Predictive Value of Tests; Retrospective Studies; Young Adult | 2018 |
Fibromyalgia.
Topics: Analgesics, Opioid; Fibromyalgia; Humans; Naltrexone; Narcotic Antagonists | 2016 |